News
Recent research highlights the potential of non-psychoactive cannabinoids—CBD, CBG, and CBN—as promising therapeutic tools for Autism Spectrum Disorder (ASD). CBD has shown efficacy in reducing anxiety, aggression, and sleep disturbances, while CBG may support cognitive function and reduce neuroinflammation. CBN, often associated with sleep improvement, is also being studied for its neurogenic properties. The most significant benefits appear when these compounds work together in full-spectrum formulations, leveraging the entourage effect to enhance symptom relief. While further large-scale studies are needed, these findings suggest that cannabinoids could play a transformative role in ASD treatment.
Living with Parkinson’s comes with daily challenges, from muscle stiffness and tremors to sleep disturbances and discomfort. But could nature hold a key to relief? Emerging research suggests that cannabinoids—especially CBG, CBN, and full-spectrum extracts—may offer neuroprotective benefits, help ease dyskinesia and even promote better sleep. Topical cannabinoid products might also provide targeted relief for muscle tension and discomfort. With studies showing promising results, it’s time to explore whether these plant-based compounds could make a real difference. Read on to uncover the science behind cannabinoids and their potential role in Parkinson’s care
